Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
Director, Australia-Indonesia Centre (AIC) Job No.: 682761 Location: Caulfield campus Employment Type: Full-time Duration: 3-year fixed-term appointment, to commence in 2026 Remuneration: A
-
for long-term impact Why Join Us Be part of a multidisciplinary and multi-institutional centre with global impact and reach Influence strategic direction at the executive level Help drive the development
-
. This is a unique opportunity to work with pioneering bedside monitoring tools, such as ICM+ software, and support the delivery of major multi-centre clinical studies, including BONANZA-GT and PRECISION-TBI
-
them The Opportunity We’re seeking a proactive and highly organised ICU Research Project Officer to coordinate two major multi-centre clinical trials that will influence intensive care practice across
-
Remuneration: AUD 36,063 per annum (tax-free stipend) (2025 rate) Monash Engineering is a leading global centre for research consistently placing highly in international ranking lists. We engage with industry
-
- $128,126 pa HEW Level 08 (plus 17% employer superannuation) Lead the delivery of a national multi-centre telehealth clinical trial improving post-ICU recovery Work alongside work-renowned intensive car
-
research facility, and working in collaboration with both academic experts and the Australian Eating Disorders Research and Translation Centre , this role is critical in developing meaningful interventions
-
Project Manager – GUARDS Clinical Trial Job No.: 678685 Location: The Alfred Centre Employment Type: Part-time, fraction (0.8) Duration: 12-month fixed-term appointment Remuneration: Pro-rata
-
accessible online resource to support researchers. The role contributes to two core work packages: assessing the validity and utility of animal models in conditions such as psychosis, depression or anxiety and
-
are particularly difficult to treat, with poor treatment outcomes and high relapse rates. However, current treatments are moderately effective at best. Given available therapies are designed to target known core